BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19558574)

  • 1. Anterior ciliary artery ligation with simultaneous intravitreal bevacizumab: an adjuvant treatment for end-stage neovascular glaucoma.
    Ghaffariyeh A; Honarpisheh N
    Acta Ophthalmol; 2010 Jun; 88(4):e133. PubMed ID: 19558574
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal bevacizumab for neovascular glaucoma.
    Andrijević-Derk B; Vatavuk Z; Bencić G; Novak-Laus K; Mandić Z
    Acta Clin Croat; 2008 Sep; 47(3):175-9. PubMed ID: 19175068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results in neovascular glaucoma treatment].
    Macarie SS; Macarie D
    Oftalmologia; 2011; 55(2):98-100. PubMed ID: 21888077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for neovascular glaucoma.
    Jonas JB; Golubkina L; Libondi T; Rensch F
    Acta Ophthalmol; 2010 Mar; 88(2):e22-3. PubMed ID: 19519731
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma.
    Miki A; Oshima Y; Otori Y; Kamei M; Tano Y
    Br J Ophthalmol; 2008 Oct; 92(10):1431-3. PubMed ID: 18815428
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
    Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
    J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
    Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
    J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
    Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
    Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA; Shahien EA; Hussein AM
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intravitreal bevacizumab in neovascular glaucoma.
    Gheith ME; Siam GA; de Barros DS; Garg SJ; Moster MR
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):487-91. PubMed ID: 17900231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of intravitreal bevacizumab in neovascular glaucoma: a case report.
    Kelkar AS; Kelkar SB; Kelkar JA; Nagpal M; Patil SP
    Bull Soc Belge Ophtalmol; 2007; (303):43-5. PubMed ID: 17894286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
    Kitnarong N; Chindasub P; Metheetrairut A
    Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab in a patient with neovascular glaucoma.
    Kahook MY; Schuman JS; Noecker RJ
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):144-6. PubMed ID: 16583637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
    Ouhadj O; Chergui I; Mendil L; Nouri MT
    J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma.
    Ghosh S; Singh D; Ruddle JB; Shiu M; Coote MA; Crowston JG
    Clin Exp Ophthalmol; 2010 May; 38(4):353-7. PubMed ID: 20665941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery].
    Lüke J; Lüke M; Grisanti S
    Ophthalmologe; 2009 May; 106(5):407-12. PubMed ID: 19418055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.